Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones

Anticancer Research

Volumn 25, Issue 5, 2005, Pages 3259-3262

  Ferreira, Maria José Umbelino ^a   Gyémánt, Nora ^b   Madureira, Ana M ^a   Molnár, Joseph ^b  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Diterpenes; Euphorbia; Helioscopinolides; Multidrug resistance

Indexed keywords

DITERPENE; GLYCOPROTEIN P; HELIOSCOPINOLIDE A; HELIOSCOPINOLIDE B; HELIOSCOPINOLIDE E; HELIOSCOPINOLIDE F; LACTONE; NATURAL PRODUCT; PLANT EXTRACT; RHODAMINE 123; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL GROWTH; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; EUPHORBIA; GROWTH INHIBITION; INFRARED SPECTROSCOPY; LYMPHOMA CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CELL LINE;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; DITERPENES, ABIETANE; DRUG RESISTANCE, NEOPLASM; EUPHORBIA; LEUKEMIA L5178; MICE; P-GLYCOPROTEIN; PLANT EXTRACTS;

EID: 23344452864     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Grossi A and Biscardi M: Reversal of MDR by verapamil analogues. Hematology 9: 47-56, 2004.
2. Teodori E, Dei S, Scapecchi S and Gualtieri F: The medicinal chemistry of multidrug resistance (MDR) reversing drugs. Il Fármaco 57: 385-415, 2002.
3. Robert J and Jarry C: Multidrug resistance reversal agents. J Med Chem 46: 4805-4817, 2003.
4. Hartwell JL: Plants used against cancer. A survey. Lloydia 62: 153-205, 1969.
5. Valente C, Ferreira MJU, Abreu PM, Gyémánt N, Ugocsai K, Hohmann J and Molnár J: Pubescenes, jatrophane diterpenes, from Euphorbia pubescens with multidrug resistance reversing activity on mouse lymphoma cells. Planta Med 70: 81-84, 2004.
6. Madureira AM, Gyémánt N, Ugocsai K, Ascenso JR, Abreu PM, Hohmann J, Molnár J and Ferreira MJU: Rearranged jatrophane-type diterpenes from Euphorbia species. Evaluation of their effect on the reversal of multidrug resistance. Planta Med 70: 45-49, 2004.
7. Hohmann J, Molnár J, Rédei D, Evanics F, Forgó P, Kálmán A, Argay Gy and Szabó P: Discovery and biological evaluation of a new family of potent modulators of multidrug resistance: reversal of MDR of mouse lymphoma cells by new natural jatrophane diterpenoids isolated from Euphorbia species. J Med Chem 45: 2425-2431, 2002.
8. Corea G, Fattorusso E, Lanzotti V, Taglialatela-Scafati O, Appendino G, Ballero M, Simon PN, Dumontet C and Di Pietro A: Modified jatrophane diterpenes as modulators of multidrug resistance from Euphorbia dendroides. Bioorg Med Chem 11: 5221-5227, 2003.
9. Corea G, Fattorusso E, Lanzotti V, Motti R, Simon PN, Dumontet C and Di Pietro A: Jatrophane diterpenes as modulators of multidrug resistance. Advances of structure-activity relationships and discovery of the potent lead pepluanin A. J Med Chem 47: 988-992, 2004.
10. Miglietta A, Gabriel L, Appendino G and Bocca C: Biological properties of jatrophane polyesters, new microtubule-interacting agents. Cancer Chemother Pharmacol 51: 67-74, 2003.
11. Valente C, Pedro M, Duarte A, Nascimento MSJ, Abreu PM and Ferreira MJU: Bioactive diterpenoids, a new jatrophane and two ent-abietanes, and other constituents from Euphorbia pubescens. J Nat Prod 67: 902-904, 2004.
12. Marco JA, Sanz-Cervera JF, Yuste A and Jakupovic J: Isoterracinolides A and B, novel bishomoditerpene lactones from Euphorbia terracina. J Nat Prod 62: 110-113, 1999.
13. Sutthivaiyakit S, Thapsut M and Prachayasittikul V: Constituents and bioactivity of the tubers of Euphorbia sessiliflora. Phytochemistry 53: 947-950, 2000.
14. Cornwell MM, Pastan I and Gottesmann MM: Certain calcium channel blockers bind specifically to multidrug-resistance human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262: 2166-2170, 1987.
15. Weaver JL, Szabo G, Pine PS, Gottesman MM, Goldenberg S and Aszalos A: The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multidrug transporter. Int J Cancer 54: 456-461, 1993.
16. Kessel D: Explorating multidrug resistance using Rhodamine 123. Cancer Commun 1: 145-149, 1989.
17. Frenkel GD and Caffrey PB: A prevention strategy for circumventing drug resistance in cancer chemotherapy. Curr Pharm Des 7: 1595-1614, 2001.